Connect with us
Scientists at ETH Zurich have made significant progress in developing a ready-to-use immunotherapy treatment for cancer. A synthetic protein modification can allow immune cells from any...
According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent of patients...
Cancer is a condition that involves the development of abnormal cells in a certain part of the body that divide uncontrollably, so much so that it...
